3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
2
Thrombocythemia, Essential
1
Stomatitis
1
Stomach Neoplasms
1
Radiation Pneumonitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Glioblastoma
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Breast Neoplasms
1
Attention Deficit Disorder with Hyperactivity
1
Acute Kidney Injury
1
Interventions
Injections
13
pembrolizumab
10
tislelizumab
9
toripalimab
6
atezolizumab
4
Nivolumab
4
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
lenvatinib
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Gemcitabine
2
Fluorouracil
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Bevacizumab
2
zimberelimab
1
talazoparib
1
spartalizumab
1
sotorasib
1
serabelisib
1
penpulimab
1
niraparib
1
nedaplatin
1
mirdametinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
Acetylcysteine
×
1 year
×
Clear all
No trials found.